The European Network for the Study of Adrenal Tumors staging system (2015): a United States validation.
Letizia Maria Ippolita JannelloReha-Baris IncesuSimone MorraLukas ScheipnerAndrea BaudoMario de AngelisCarolin SiechZhe TianJordan A GoyalStefano LuzzagoFrancesco A MistrettaMatteo FerroFred SaadShahrokh F ShariatFelix K H ChunAlberto BrigantiDerya TilkiSascha AhyaiLuca CarmignaniNicola LongoOttavio de CobelliGennaro MusiPierre I KarakiewiczPublished in: The Journal of clinical endocrinology and metabolism (2024)
The accuracy of mENSAT is virtually the same as that of AJCC in predicting CSM (74.7 vs. 74.5%) and OM (73.7 vs. 73.5%). However, calibration is lower for mENSAT than for AJCC. In consequence, no obvious benefit appears to be associated with the use of mENSAT relative to AJCC in United States ACC patients.